MedTrace Logo

Artificial Intelligence, and E-Health Literacy in Fibromyalgia

NCT07020845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 212

Last updated 2025-06-13

No results posted yet for this study

Summary

This cross-sectional observational study aimed to assess electronic health literacy and artificial intelligence literacy among individuals diagnosed with fibromyalgia syndrome, with particular focus on artificial intelligence literacy. Although general health literacy has been investigated in this patient population, digital and artificial intelligence-related competencies have not been sufficiently studied. The research included 106 individuals diagnosed with fibromyalgia syndrome and 106 age- and sex-matched healthy volunteers, recruited between December 2024 and May 2025. All participants completed a series of standardized questionnaires, including the Revised Fibromyalgia Impact Questionnaire, the Beck Depression Inventory, the Beck Anxiety Inventory, the Electronic Health Literacy Scale, and the Artificial Intelligence Literacy Scale. The study explored demographic, clinical, and psychological factors associated with digital and artificial intelligence literacy levels among both patient and control groups.

Conditions

  • Fibromyalgia Syndrome
  • Healthy Controls Group - Age and Sex-matched

Interventions

OTHER

Observation only

This is an observational study with no intervention applied to participants. Data were collected through questionnaires and clinical assessments only

Sponsors & Collaborators

  • Gulseren Demir Karakilic

    lead OTHER

Principal Investigators

  • Gülseren Demir Karakılıç, Assistant Professor · Yozgat Bozok University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-16
Primary Completion
2025-05-30
Completion
2025-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07020845 on ClinicalTrials.gov